Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Malignant neoplasm of colon and/or rectum
0.100 Biomarker disease BEFREE YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer. 30531836 2019
Malignant neoplasm of colon and/or rectum
0.100 Biomarker disease BEFREE MALAT1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility. 30797712 2019
Malignant neoplasm of colon and/or rectum
0.100 Biomarker disease BEFREE Inhibition of MALAT1 reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer. 30716387 2019
Malignant neoplasm of colon and/or rectum
0.100 Biomarker disease BEFREE Multivariate Cox regression analysis showed that MALAT1 was a poor prognostic factor of colorectal cancer. 31311811 2019
Malignant neoplasm of colon and/or rectum
0.100 Biomarker disease BEFREE Nonetheless, whether Malat1 participates in the autophagy of colorectal cancer remains unclear. 31372165 2019
Malignant neoplasm of colon and/or rectum
0.100 AlteredExpression disease BEFREE Collectively, we concluded that MALAT1 functioned as a ceRNA to promote colorectal cancer development and EZH2 expression through sponging miR-363-3p <i>in vitro</i> and <i>in vivo</i>. 30972996 2019
Malignant neoplasm of colon and/or rectum
0.100 AlteredExpression disease BEFREE In particular, increased MALAT1 expression levels were significantly associated with decreased OS in patients with colorectal cancer (HR, 3.04; 95% CI, 1.77-4.31). 30719108 2019
Malignant neoplasm of colon and/or rectum
0.100 Biomarker disease BEFREE The long non-coding RNA MALAT1 promotes epithelial-mesenchymal transition and angiogenesis in colorectal cancer, but it is unknown whether it affects the stemness of gastric cancer cells. 31037832 2019
Malignant neoplasm of colon and/or rectum
0.100 AlteredExpression disease BEFREE MALAT1 can be aberrantly expressed in hepatocellular carcinoma, cervical, breast, ovarian cancers, as well as colorectal cancer. 29096355 2018
Malignant neoplasm of colon and/or rectum
0.100 GeneticVariation disease BEFREE Association study of genetic variation of lncRNA MALAT1 with carcinogenesis of colorectal cancer. 30538572 2018
Malignant neoplasm of colon and/or rectum
0.100 Biomarker disease BEFREE LncRNA MALAT1 could facilitate colorectal cancer cell proliferation, invasion and migration by down-regulating miR-145 and up-regulating SOX9. 30285605 2018
Malignant neoplasm of colon and/or rectum
0.100 Biomarker disease BEFREE MALAT1 promotes the colorectal cancer malignancy by increasing DCP1A expression and miR203 downregulation. 29964337 2018
Malignant neoplasm of colon and/or rectum
0.100 Biomarker disease BEFREE EZH2 is highly expressed and associated with the 3' end region of lncRNA MALAT1 in colorectal cancer, and this association suppressed the expression of E-cadherin. 28069878 2017
Malignant neoplasm of colon and/or rectum
0.100 AlteredExpression disease BEFREE Recent studies have demonstrated that MALAT1 is involved in cancer metastasis and recurrence and it is up-regulated in cervical cancer, hepatocellular carcinoma, non-small cell lung cancer (NSCLC) and colorectal cancer. 26406400 2015
Malignant neoplasm of colon and/or rectum
0.100 AlteredExpression disease BEFREE An aberrant expression of MALAT1 was observed in hepatocellular carcinoma, cervical cancer, breast cancer, ovarian cancer, and colorectal cancer. 25431257 2015
Malignant neoplasm of colon and/or rectum
0.100 Biomarker disease BEFREE High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. 25031737 2014
Malignant neoplasm of colon and/or rectum
0.100 Biomarker disease BEFREE MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. 21503572 2011